Zobrazeno 1 - 10
of 157
pro vyhledávání: '"Jordi Monfort"'
Autor:
Maria Segarra-Queralt, Mar Galofré, Laura Tio, Jordi Monfort, Joan Carlos Monllau, Gemma Piella, Jérôme Noailly
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-11 (2024)
Abstract Knee osteoarthritis (OA) diagnosis is based on symptoms, assessed through questionnaires such as the WOMAC. However, the inconsistency of pain recording and the discrepancy between joint phenotype and symptoms highlight the need for objectiv
Externí odkaz:
https://doaj.org/article/8f66f58142694d53aa1ee5e942a7e48b
Autor:
Andrea Doreste, Jesus Pujol, Eva Penelo, Víctor Pérez, Laura Blanco-Hinojo, Gerard Martínez-Vilavella, Helena Pardina-Torner, Fabiola Ojeda, Jordi Monfort, Joan Deus
Publikováno v:
Frontiers in Psychology, Vol 15 (2024)
BackgroundFibromyalgia (FM) is a complex rheumatic disorder characterized by chronic nociplastic pain and central sensitization. Psychopathological conditions can influence FM symptoms, which worsen their condition. However, not all patients with FM
Externí odkaz:
https://doaj.org/article/0e13fa74cebd4b529e20ce15f5ec4d56
Autor:
Irene Carrión-Barberà, Laura Triginer, Laura Tío, Carolina Pérez-García, Anna Ribes, Victoria Abad, Ana Pros, Jordi Monfort, Tarek Carlos Salman-Monte
Publikováno v:
Biomedicines, Vol 12, Iss 3, p 610 (2024)
It has been postulated that advanced glycation end products (AGEs) and their soluble receptor (sRAGE) may play a relevant role as inducers in the chronic inflammatory pathway in various conditions, among them, in immune-mediated diseases such as syst
Externí odkaz:
https://doaj.org/article/a1846b98d44549d39fe9699342f9f718
Autor:
Irene Carrión-Barberà, Laura Triginer, Laura Tío, Carolina Pérez-García, Anna Ribes, Victoria Abad, Ana Pros, Marcelino Bermúdez-López, Eva Castro-Boqué, Albert Lecube, José Manuel Valdivielso, ILERVAS Project Group, Jordi Monfort, Tarek Carlos Salman-Monte
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 5, p 3022 (2024)
Advanced glycation end-products (AGEs) may play a relevant role as inducers in the chronic inflammatory pathway present in immune-mediated diseases, such as systemic lupus erythematosus (SLE). AGEs concentrations have been associated, with discrepant
Externí odkaz:
https://doaj.org/article/a58436b6328a494795ab694ec0627354
Autor:
Jesus Pujol, Laura Blanco-Hinojo, Andrea Doreste, Fabiola Ojeda, Gerard Martínez-Vilavella, Víctor Pérez-Sola, Joan Deus, Jordi Monfort
Publikováno v:
Arthritis Research & Therapy, Vol 24, Iss 1, Pp 1-13 (2022)
Abstract Background Pain-sensitized osteoarthritis and fibromyalgia patients characteristically show nociceptive system augmented responsiveness as a common feature. However, sensitization can be originally related to the peripheral injury in osteoar
Externí odkaz:
https://doaj.org/article/4f10018014d64ca481c6440b5763ad77
Publikováno v:
BMC Musculoskeletal Disorders, Vol 23, Iss 1, Pp 1-10 (2022)
Abstract Background Pronolis®HD mono 2.5% is a novel, one-shot, high-density sterile viscoelastic solution, recently available in Spain, which contains a high amount of intermediate molecular weight hyaluronic acid (HA), highly concentrated (120 mg
Externí odkaz:
https://doaj.org/article/cda575fa848849f592e0cf2bbd0a8bf1
Autor:
Maria Segarra-Queralt, Michael Neidlin, Laura Tio, Jordi Monfort, Joan Carles Monllau, Miguel Á. González Ballester, Leonidas G. Alexopoulos, Gemma Piella, Jérôme Noailly
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-16 (2022)
Abstract In osteoarthritis (OA), chondrocyte metabolism dysregulation increases relative catabolic activity, which leads to cartilage degradation. To enable the semiquantitative interpretation of the intricate mechanisms of OA progression, we propose
Externí odkaz:
https://doaj.org/article/22d4edc592104ad39a6ec546b3fdbba6
Autor:
Nuria Carballo, Carolina Pérez García, Santiago Grau, Jordi Monfort, Xavier Durán-Jordà, Daniel Echeverría-Esnal, Olivia Ferrández
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Although several randomized clinical trials have confirmed that there is no difference in efficacy between etanercept and its biosimilar versions in the treatment of rheumatoid arthritis (RA), limited real-world evidence is available. We conducted a
Externí odkaz:
https://doaj.org/article/50fe152024be49b7ab243564e0da6217
Autor:
Antonio Julià, María López-Lasanta, Francisco Blanco, Antonio Gómez, Isabel Haro, Antonio Juan Mas, Alba Erra, Ma Luz García Vivar, Jordi Monfort, Simón Sánchez-Fernández, Isidoro González, Mercedes Alperi, Raúl Castellanos-Moreira, Antonio Fernández-Nebro, César Díaz-Torné, Núria Palau, Raquel Lastra, Jordi Lladós, Raimon Sanmartí, Sara Marsal
Publikováno v:
BMC Musculoskeletal Disorders, Vol 22, Iss 1, Pp 1-7 (2021)
Abstract Background Blocking of the Tumor Necrosis Factor (TNF) activity is a successful therapeutic approach for 50–60% of rheumatoid arthritis (RA) patients. However, there are yet no biomarkers to stratify patients for anti-TNF therapy. Rheumato
Externí odkaz:
https://doaj.org/article/4d4a47f028c54e7ba390d56616766d68
Autor:
Marianna Vitaloni, Angie Botto-van Bemden, Rosa Sciortino, Xavier Carné, Maritza Quintero, Pedro Santos-Moreno, Rolando Espinosa, Oscar Rillo, Jordi Monfort, Francisco de Abajo, Elizabeth Oswald, Marco Matucci, Patrick du Souich, Ingrid Möller, Montserrat Romera Baures, Arlene Vinci, Deborah Scotton, Marco Bibas, Guy Eakin, Josep Verges
Publikováno v:
BMC Musculoskeletal Disorders, Vol 21, Iss 1, Pp 1-9 (2020)
Abstract Background Globally, osteoarthritis (OA) is the third condition associated with disability. There is still poor treatment in OA but science holds the key to finding better treatments and a cure. It is essential to learn what’s important to
Externí odkaz:
https://doaj.org/article/af0ef8d46de2467c91fef8b72ee60687